Oxaliplatin

Neurotoxicity from 
oxaliplatin

Neurotoxicity from 
oxaliplatin

By

What are some of the potential autonomic issues related to acute neurotoxicity from oxaliplatin?

A new era in management of
 gastrointestinal cancers

A new era in management of
 gastrointestinal cancers

By

Key studies presented at the 2011 Oncology Congress focus on treatments, prevention, and early diagnosis of GI tract cancers.

Combination therapy in metastatic CRC

Adding cetuximab to the treatment regimen of patients with metastatic colorectal cancer (CRC) results in worse outcomes, a controlled trial has shown.

Use of an enzyme inhibitor in treating pancreatic cancer

Resistance to chemotherapy is one of the greatest challenges in pancreatic cancer treatment. However, US researchers have found that inhibiting the enzyme TAK-1 can overcome this.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs